Metabolism and Toxicity of 2-Methylpropene (Isobutene) — A Review

REFERENCE

• Morrow N. The industrial production and use of 1,3-butadiene. Environ. Health Perspect. 1990; 86: 7
   PubMed Web of Science ®Google Scholar
• De Meester C. Genotoxic properties of 1,3-butadiene. Mutat. Res. 1988; 195: 273
   PubMed Web of Science ®Google Scholar
• Laib R. J., Filser J., Kreiling R., Vangala R., Bolt H. M. Inhalation pharmacokinetics of 1,3-butadiene and 1,2-epoxybutene-3 in rats and mice. Environ. Health Perspect. 1990; 86: 57
   PubMed Web of Science ®Google Scholar
• Mehlman M., Legator M. Dangerous and cancer-causing properties of products and chemicals in the oil refining and petrochemical industry. II. Carcinogenicity, mutagenicity and developmental toxicity of 1,3-butadiene. Toxicol. Ind. Health 1991; 7: 207
   PubMed Web of Science ®Google Scholar
• Melnick R., Huff J. 1, 3-Butadiene: toxicity and carcinogenicity in laboratory animals and humans. Rev. Environ. Contain. Toxicol. 1992; 124: 111
   PubMed Web of Science ®Google Scholar
• Jenkins Sumner S., Fennell T. R. Review of the metabolic fate of styrene. Crit. Rev. Toxicol. 1994; 24(S1)S11
   Google Scholar
• Roe F. J. C. Styrene: toxicity studies — what do they show. Crit. Rev. Toxicol. 1994; 24(S1)S117
   Google Scholar
• McConnell E. E., Swenberg J. A. Review of styrene and styrene oxide long-term animal studies. Crit. Rev. Toxicol. 1994; 24(S1)S49
   Google Scholar
• IARC (International Agency of Research on Cancer). IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. LyonFrance 1992; Vol. 54
   Google Scholar
• Kennedy J., Kirshenbaum I. Isobutylene. Vinyl and Diene Monomers, E. Leonard. Wiley-Interscience, New York 1971; Vol. 2: 691
   Google Scholar
• Chemie BG. 2-Methylpropene. Toxicological Evaluations, Berufsgenossenschaft der chemischen Industrie. Springer-Verlag, Heidelberg 1989; Vol. 2: 153
   Google Scholar
• Chemie BG. Toxicological Evaluations, Berufsgenossenschaft der chemischen Industrie. Springer-Verlag, Heidelberg 1992; Vol. 4: 1
   Google Scholar
• Chemical and Engineering News. Production by the US Chemical Industry. 1992; 36
   Google Scholar
• Henderson R. F., Sabourin P. J., Bechtold W. E., Steinberg B., Chang I.-Y. Disposition of inhaled isobutene in F344/N rats. Toxicol. Appl. Pharmacol. 1993; 123: 50
   PubMed Web of Science ®Google Scholar
• McDermott H. J., Killiany S. E. Quest for a gasoline TLV. Am. Ind. Hyg. Assoc. J. 1978; 39: 110
   PubMed Web of Science ®Google Scholar
• Hempel V., May R., Frank H., Remmer H., Koster U. Isobutene formation during halothane anaesthesia in man. Br. J. Anaesth. 1980; 2: 989
   Google Scholar
• Frank H., Hintze T., Bimboes D., Remmer H. Monitoring lipid peroxidation by breath analysis — endogenous hydrocarbons and their metabolite elimination. Toxicol. Appl. Pharmacol. 1980; 56: 337
   PubMed Web of Science ®Google Scholar
• Shugaev B. B., Yaroslavl B. Concentrations of hydrocarbons in tissues as a measure of toxicity. Arch. Environ. Health 1969; 18: 878
   PubMed Web of Science ®Google Scholar
• Csanády G. A., Freise D., Denk B., Filser J. G., Cornet M., Rogiers V., Laib R. J. Investigation of species differences in isobutene (2-methylpropene) metabolism between mice and rats. Arch. Toxicol. 1991; 65: 100
   PubMed Web of Science ®Google Scholar
• Cornet M., Sonck W., Callaerts A., Csanády G., Vercruysse A., Laib R. J., Rogiers V. In vitro biotransformation of 2-methylpropene (isobutene) — epoxide formation in mice liver. Arch. Toxicol. 1991; 65: 263
   PubMedGoogle Scholar
• Cornet M., Callaerts A., Jorritsma U., Bolt H. M., Vercruysse A., Rogiers V. Species-dependent differences in biotransformation pathways of 2-methylpropene (isobutene). Chem. Res. Toxicol. 1995; 8: 987
   PubMedGoogle Scholar
• Cornet M., Mertens K., Callaerts A., Sonck W., Vercruysse A., Rogiers V. Age- and gender-related changes in the hepatic metabolism of 2-methyl-propene and relationship to epoxide metabolising enzymes. Mech. Age. Dev. 1994; 74: 103
   PubMedGoogle Scholar
• Cornet M., Callaerts A., Vercruysse A., Rogiers V. In vitro biotransformation of 2-methyl-propene (isobutene) in rat lung tissue in comparison with liver tissue. Arch. Toxicol. 1995; 70: 64
   PubMedGoogle Scholar
• Maynert E., Foreman R., Watabe T. Epoxides as obligatory intermediates in metabolism of olefins to glycols. J. Biol. Chem. 1970; 254: 5234
   Google Scholar
• Miller E., Miller J. Some historical perspectives on the metabolism of xenobiotic chemicals to reactive electrophiles. Bioactivation of Foreign Compounds, M. Anders. Academic Press, Orlando 1985; 3
   Google Scholar
• Hayashi S., Watanabe J., Kawajiri K. Genetic polymorphisms in the 5′-flanking region change transcriptional regulation of the human cytochrome P450IIE1 gene. J. Biochem. 1991; 110: 559
   PubMed Web of Science ®Google Scholar
• Guengerich F. P., Kim D.-H., Iwasaki M. Role of human cytochrome P-450IIE1 in the oxidation of low molecular weight cancer suspects. Chem. Res. Toxicol. 1991; 4: 168
   PubMed Web of Science ®Google Scholar
• Devereux T., Domin B., Philpot R. Xenobiotic metabolism by isolated pulmonary cells. Pharmacol Ther. 1989; 41: 243
   PubMed Web of Science ®Google Scholar
• Guengerich F. P. Purification and characterization of xenobiotic metabolizing enzymes from lung tissue. Pharmacol Ther. 1990; 45: 299
   PubMed Web of Science ®Google Scholar
• Minchin R., Boyd M. Localization of metabolic activation and deactivation systems in the lung — significance to the pulmonary toxicity of xenobiotics. Annu. Rev. Pharmacol Toxicol. 1983; 23: 217
   PubMed Web of Science ®Google Scholar
• Glatt H., Oesch F. Species differences in enzymes controlling reactive epoxides. Arch. Toxicol. 1987; 111, Suppl. 10
   Google Scholar
• Persson I., Johansson I., Bergling H., Dahl M., Seidegard J., Rylander R., Rannug A., Högberg J., Sundberg M. Genetic polymorphism of cytochrome P4502E1 in a Swedish population. FEBS Lett. 1993; 319: 207
   PubMed Web of Science ®Google Scholar
• Corrigall A., Kirsch R. Glutathione S-transferuse distribution and concentration in human organs. Biochem. Int. 1988; 16: 443
   PubMedGoogle Scholar
• Van Bladeren P., Ploemen J., Ommen B. Glutathione S-transferase polymorphisms in relation to toxicity. Developments and Ethical Considerations in Toxicology, M. Weitzner. Royal Society of Chemistry, CambridgeEngland 1993; 69
   Google Scholar
• Hassett C., Aisher L., Sidhu J., Omiecinski C. Human microsomal epoxide hydrolase — genetic polymorphism and functional expressionin vitro of amino acid variants. Hum. Mol Genet. 1994; 3: 421
   PubMed Web of Science ®Google Scholar
• Shugaev B. B. Effective brain tissue concentration of jointly administered aliphatic hydrocarbons as exemplified by butane and isobutylene. Pharmacol. Toxicol. 1967; 1: 54
   Google Scholar
• Bolt H. M., Laib R. J. Covalent binding of drug metabolites to DNA — a tool of predictive value. Arch. Toxicol. 1980; 46: 171
   PubMed Web of Science ®Google Scholar
• Leutbecher M., Cornet M., Rogiers V., Bolt H. M. DNA binding study with inhaled [14C]2-methylpropene (isobutene). Arch. Toxicol. 1994; 68: 71
   PubMedGoogle Scholar
• Staab R. J., Sarginson N. J. Lack of genetic toxicity of isobutylene gas. Mutat. Res. 1984; 130: 259
   Google Scholar
• Shimizu H., Suzuki Y., Takemura N., Goto S., Matsusjita H. The results of microbial mutation tests for forty-three industrial chemicals. Jpn. J. Ind. Health 1985; 27: 400
   PubMedGoogle Scholar
• Cornet M., Castelain P., Vercruysse A., Laib R. J., Kirsch-Volders M., Rogiers V. Mutagenicity of 2-methylpropene (isobutene) and its epoxide in a modified Salmonella assay for volatile compounds. Mutat. Res. 1992; 271: 213
   PubMedGoogle Scholar
• Jorritsma U., Cornet M., Van Hummelen P., Bolt H. M., Vercruysse A., Kirsch-Volders M., Rogiers V. Comparative mutagenicity of 2-methylpropene (isobutene), its epoxide and propylene oxide in thein vitro micronucleus test using human lymphocytes. Mutagenesis 1995; 10: 101
   PubMed Web of Science ®Google Scholar
• Guengerich F. P., Liebler D. C. Enzymatic activation of chemicals to toxic metabolites. CRC Crit. Rev. Toxicol. 1985; 14: 259
   Web of Science ®Google Scholar
• Manson M. Epoxides — is there a human health problem. Br. J. Ind. Med. 1980; 37: 317
   PubMedGoogle Scholar
• Boyland B. The metabolism of foreign compounds and the induction of cancer. Xenobiotica 1986; 16: 899
   PubMed Web of Science ®Google Scholar
• Oesch F. Significance of various enzymes in the control of reactive metabolites. Arch. Toxicol. 1987; 60: 174
   PubMed Web of Science ®Google Scholar
• Monks T., Lau S. Reactive intermediates and their toxicological importance. Toxicology 1988; 52: 1
   PubMed Web of Science ®Google Scholar
• Oesch F., Doehmer J., Friedberg T., Glatt H., Oesch-Bartlomowicz B., Piatt K., Steinberg P., Utesch D., Thomas H. Control of ultimate mutagenic species by diverse enzymes. Prog. Clin. Biol. Res. 1990; 340: 49
   Google Scholar
• Miller E., Miller J. Searches for ultimate chemical carcinogens and their reactions with cellular macromolecules. Cancer 1981; 47: 2327
   PubMed Web of Science ®Google Scholar
• Oesch F., Doehmer J., Friedberg T., Glatt H., Oesch-Bartlomowicz B., Piatt K., Steinberg P., Utesch D., Thomas H. Toxicological implications of enzymatic control of reactive metabolites. Hum. Exp. Toxicol. 1990; 9: 171
   PubMed Web of Science ®Google Scholar